Author

S. Kumar Deshmukh

Observed names: S. Deshmukh, S. K. Deshmukh

Institution: Caris Life Sciences (United States)

Observed institution: Caris Life Sciences (United States)

OpenAlex ID: A5126465729

Abstract PS2-09-08: Tertiary lymphoid structure (TLS)-related gene expression and outcomes in HER2-Positive (HER2+) breast cancer (BC) in the Real-World Database

2026 · S. Chumsri, S. Deshmukh, et al. · Clinical Cancer Research

Abstract PS2-08-14: Chemokine signatures improve PD-L1-based prediction of pembrolizumab response in triple-negative breast cancer

2026 · S. Gandhi, S. Deshmukh, et al. · Clinical Cancer Research

Abstract PS2-10-25: Combined T and B cell signatures as prognostic biomarkers in triple-negative breast cancer (TNBC)

2026 · S. Gandhi, S. Kumar Deshmukh, et al. · Clinical Cancer Research

Abstract PS2-09-19: Tonsl, an immortalizing oncogene on chr.8q24.3 amplicon, confers intrinsic resistance to cdk4/6 inhibitors in breast cancer

2026 · H. Nakshatri, A. S. Khatpe, et al. · Clinical Cancer Research

Abstract PS2-08-04: Site specific Genomic and Immune Landscapes Underpinning in metastatic Male Breast Cancer

2026 · D. Trapani, S. Deshmukh, et al. · Clinical Cancer Research

Works count: 5

Citation count:

H-index:

I10-index: